SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-24-030234
Filing Date
2024-06-27
Accepted
2024-06-27 07:04:55
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-06-27

Document Format Files

Seq Description Document Type Size
1 ARS avtx10-k2023_wrap.pdf ARS 15462441
  Complete submission text file 0001628280-24-030234.txt   21300292
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37590 | Film No.: 241075358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)